Research study Program year 2021 Source: CMS Open Payments

A Phase 1, Two-Part, Double-Blind, Active Control, Randomized Study to

Research payments

$3,468,435

38 payments

Through program year 2021, $3,468,435 in research payments was reported against A Phase 1, Two-Part, Double-Blind, Active Control, Randomized Study to, across 38 payments, paid by ViiV Healthcare Company.

Paid by: ViiV Healthcare Company
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$3,275,312	29
2020	Research	$193,123	9

Breakdown

Who paid Research payments · program years 2020–2021

ViiV Healthcare Company $3,468,435 38 payments

Who received the money Research payments · program years 2020–2021

Ppd Development LP Organisation paid for research $1,664,808 23 payments
Ppd Development INC Clinics Organisation paid for research $1,065,751 11 payments
Ppd Organisation paid for research $737,875 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.